The Bipolar Depression Rating Scale (BDRS) is a 20-item clinician-rated assessment specifically designed to measure depressive symptoms in patients with bipolar disorder. Developed by Michael Berk and colleagues in 2007, the BDRS addresses a critical gap in psychiatric assessment by capturing features unique to bipolar depression — including atypical symptoms (hypersomnia, hyperphagia) and mixed features (irritability, mood lability, increased motor drive) — that general depression scales like the HAM-D often miss. Each item is scored on a 4-point Likert scale from 0 (“Nil”) to 3 (“Severe”), yielding a total score range of 0–60, with higher scores indicating greater bipolar depression severity. The BDRS demonstrates excellent psychometric properties with Cronbach’s α = 0.917 and strong correlations with the MADRS (r = 0.906) and HAM-D (r = 0.744) (Berk et al., 2007). Zentake’s digital BDRS provides automated scoring, HIPAA-compliant administration, and longitudinal tracking for bipolar depression management.
The BDRS uses a 4-point Likert-type rating system where clinicians rate each of the 20 items based on the patient’s responses during a semi-structured clinical interview. Response options range from 0 (“Nil”) to 3 (“Severe”). The total score is calculated by summing all 20 items, producing a range of 0–60.
The BDRS yields two clinically meaningful subscale scores:
There is no universally established clinical cutoff score for the BDRS; however, higher total scores indicate greater bipolar depression severity and the need for closer clinical monitoring and possible treatment adjustment. Factor analysis identifies three underlying constructs: psychological depressive symptoms, somatic depressive symptoms, and mixed symptoms (Berk et al., 2007).
Zentake automatically calculates total scores and subscale scores upon form submission, providing instant clinical feedback and trend visualization across administrations.
Step 1: Confirm the clinical context. The BDRS is designed for patients with an established diagnosis of bipolar disorder (Type I or Type II) who are currently experiencing or being monitored for depressive episodes. Ensure the patient’s bipolar diagnosis has been confirmed before administering the BDRS. Zentake’s patient records can flag the relevant diagnostic history.
Step 2: Conduct the semi-structured interview. The BDRS is clinician-rated, meaning the clinician rates each item based on the patient’s verbal responses and observed behavior during a clinical interview. Ask about each symptom domain, probing for severity, frequency, and functional impact over the past week. Zentake presents each item with built-in prompts to guide the clinical interview.
Step 3: Rate each item on the 0–3 scale. For each of the 20 items, select the severity rating that best matches the patient’s presentation: 0 = Nil, 1 = Mild, 2 = Moderate, 3 = Severe. Pay particular attention to the mixed symptoms subscale (items 16–20), as these features distinguish bipolar from unipolar depression.
Step 4: Review total and subscale scores. After completing all items, review the total score (0–60), depressive subscale (0–45), and mixed subscale (0–15). Zentake automatically calculates these scores and displays them alongside previous administrations for longitudinal comparison.
Step 5: Integrate into treatment planning. Use BDRS scores alongside other clinical information to inform medication management, therapy adjustments, and safety planning. Track score changes across visits to monitor treatment response. Zentake’s measures dashboard provides graphical trend visualization and automatic change-score calculations.
Scoring: Paper BDRS requires manual addition of 20 items and separate subscale calculation. Zentake automatically computes total score, depressive subscale, and mixed subscale instantly upon completion.
Completion: Paper administration requires the clinician to record ratings on a printed form during the interview. Zentake’s digital interface allows real-time rating entry on a tablet or computer during the clinical interview.
Delivery: Paper forms must be printed, stored, and physically available in the exam room. Zentake makes the BDRS available on any device through the clinician portal, ensuring it’s always accessible.
Data storage: Paper BDRS forms require filing in patient charts with limited searchability. Zentake stores all BDRS data in HIPAA-compliant encrypted cloud storage with full audit trails.
Longitudinal tracking: Comparing paper BDRS scores across visits requires manual chart review and hand-plotted graphs. Zentake automatically generates score trend charts across all administrations, highlighting clinically significant changes.
Security: Paper forms risk unauthorized access and loss. Zentake provides HIPAA-compliant storage with role-based access controls, encryption, and audit trails.
Integration: Paper scores must be manually entered into EMR and billing systems. Zentake integrates directly with major EMR platforms for seamless data transfer.
Cost: Paper administration involves ongoing printing, storage, and manual data entry costs. Zentake eliminates these expenses while improving data accuracy and clinical efficiency.
What does the BDRS measure?
The Bipolar Depression Rating Scale (BDRS) measures the severity of depressive symptoms specifically in patients with bipolar disorder. Unlike general depression scales, the BDRS captures features unique to bipolar depression including atypical symptoms (hypersomnia, increased appetite) and mixed features (irritability, mood lability, increased motor drive). Zentake’s digital version provides instant automated scoring across both subscales.
How do you score the BDRS?
The BDRS is scored by summing all 20 items, each rated 0–3, for a total score of 0–60. Two subscales can also be calculated: the depressive subscale (items 1–15, range 0–45) and the mixed symptoms subscale (items 16–20, range 0–15). Higher scores indicate greater bipolar depression severity. Zentake automatically calculates all scores upon completion.
How long does the BDRS take to administer?
The BDRS typically takes 15–25 minutes to administer as a semi-structured clinical interview, depending on clinical complexity and patient response. This is comparable to other clinician-rated depression scales like the MADRS or HAM-D. Zentake’s digital interface with built-in prompts helps maintain consistent and efficient administration.
Is the BDRS free to use?
The BDRS was published in the academic literature by Berk et al. (2007) and is available for clinical and research use. Zentake provides a digital version with automated scoring, longitudinal tracking, and EMR integration as part of its HIPAA-compliant forms platform.
What population is the BDRS designed for?
The BDRS was developed and validated for adult patients (ages 18–65) with an established diagnosis of bipolar disorder (Type I or Type II) who are experiencing or being monitored for depressive episodes. It is a clinician-rated scale requiring administration by a trained mental health professional.
Who should administer the BDRS?
The BDRS is a clinician-rated instrument that should be administered by trained mental health professionals including psychiatrists, psychiatric nurse practitioners, psychologists, and clinical researchers with expertise in bipolar disorder assessment. The clinician rates each item based on the patient’s responses during a semi-structured interview.
How is the BDRS different from the HAM-D or MADRS?
The HAM-D and MADRS were designed for unipolar depression and do not adequately capture features unique to bipolar depression such as atypical symptoms and mixed features. The BDRS was specifically developed for bipolar depression and includes a mixed symptoms subscale (items 16–20) that correlates with mania rating scales, making it uniquely suited for bipolar disorder management.
Can the BDRS detect mixed features in bipolar depression?
Yes. The BDRS mixed symptoms subscale (items 16–20) specifically assesses irritability, mood lability, increased motor drive, increased speech, and agitation. This subscale correlates with the Young Mania Rating Scale (r = 0.757), confirming its ability to detect manic features within depressive episodes — a critical clinical distinction for treatment decisions in bipolar disorder.
1. Berk, M., Malhi, G. S., Cahill, C., Carman, A. C., Hadzi-Pavlovic, D., Hawkins, M. T., ... & Mitchell, P. B. (2007). The Bipolar Depression Rating Scale (BDRS): Its development, validation and utility. Bipolar Disorders, 9(6), 571–579.
2. Lee, K. H., Kim, K. H., Oh, H. S., & Lee, S. M. (2016). Clinical assessment of bipolar depression: Validity, factor structure and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS). BMC Psychiatry, 16, 239.
3. Doria, S., De Lorenzo, R., Fiorentini, A., Galimberti, S., Di Giano, N., & Caldiroli, A. (2021). Confirmatory evaluation of the Bipolar Depression Rating Scale (BDRS) in a large sample of female patients with bipolar depression. International Journal of Psychiatry in Clinical Practice, 26(1), 67–74.
Last updated: April 2026
The leading patient intake platform. HIPAA compliant forms for healthcare providers and organizations. Find out what you're missing!
